Surmodics Inventory Turnover Ratio 2006-2019 | SRDX
Surmodics inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| Surmodics Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.543B | $0.081B |
| SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $147.856B | 28.70 |
| Medtronic (MDT) | Ireland | $133.874B | 19.12 |
| Stryker (SYK) | United States | $76.669B | 27.36 |
| Boston Scientific (BSX) | United States | $59.033B | 28.30 |
| Baxter (BAX) | United States | $41.839B | 26.37 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.060B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.618B | 40.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.965B | 16.04 |
| Lonza Group Ag (LZAGY) | Switzerland | $24.947B | 0.00 |
| Terumo (TRUMY) | Japan | $23.393B | 26.90 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.274B | 0.00 |
| ResMed (RMD) | United States | $17.745B | 33.90 |
| Canopy Growth (CGC) | Canada | $12.161B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.027B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.308B | 49.34 |
| William Demant Holdings (WILYY) | Denmark | $7.651B | 0.00 |
| Insulet (PODD) | United States | $7.203B | 524.78 |
| Aurora Cannabis (ACB) | Canada | $7.109B | 70.10 |
| Perrigo (PRGO) | Ireland | $7.004B | 11.84 |
| Hill-Rom Holdings (HRC) | United States | $6.993B | 21.20 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.325B | 51.63 |
| ICU Medical (ICUI) | United States | $5.135B | 30.64 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.057B | 0.00 |
| Neogen (NEOG) | United States | $3.349B | 54.45 |
| NuVasive (NUVA) | United States | $2.982B | 24.36 |
| Hutchison China MediTech (HCM) | China | $2.925B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.711B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.420B | 51.57 |
| Quidel (QDEL) | United States | $2.309B | 23.96 |
| Cardiovascular Systems (CSII) | United States | $1.598B | 917.80 |
| Aphria (APHA) | $1.579B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.229B | 18.41 |
| AtriCure (ATRC) | United States | $1.218B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.187B | 25.19 |
| Lantheus Holdings (LNTH) | United States | $1.089B | 28.93 |
| NanoString Technologies (NSTG) | United States | $1.056B | 0.00 |
| PetIQ (PETQ) | United States | $0.994B | 24.14 |
| MacroGenics (MGNX) | United States | $0.777B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.765B | 21.47 |
| Cerus (CERS) | United States | $0.758B | 0.00 |
| Quanterix (QTRX) | United States | $0.753B | 0.00 |
| Omeros (OMER) | United States | $0.750B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.698B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.572B | 27.71 |
| OraSure Technologies (OSUR) | United States | $0.531B | 24.43 |
| Meridian Bioscience (VIVO) | United States | $0.476B | 14.56 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.404B | 0.00 |
| Vapotherm (VAPO) | United States | $0.345B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.320B | 22.13 |
| BioLife Solutions (BLFS) | United States | $0.304B | 95.24 |
| Zynex (ZYXI) | United States | $0.250B | 25.67 |
| Bovie Medical (APYX) | United States | $0.236B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.198B | 4.20 |
| Chimerix (CMRX) | United States | $0.188B | 0.00 |
| United Health Products (UEEC) | United States | $0.175B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.170B | 0.00 |
| Female Health (VERU) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.139B | 7.33 |
| Chembio Diagnostics (CEMI) | United States | $0.098B | 0.00 |
| United-Guardian (UG) | United States | $0.094B | 20.65 |
| InfuSystems Holdings (INFU) | United States | $0.090B | 0.00 |
| Surface Oncology (SURF) | United States | $0.075B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.060B | 20.75 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.058B | 0.00 |
| MRI INTERVENTNS (MRIC) | United States | $0.052B | 0.00 |
